Sep 28, 2023 / 11:30AM GMT
Operator
Good afternoon, and welcome to the Novacyt Interim Results Investor Presentation. (Operator Instructions)
Before we begin, I'd like to submit the following poll. And for the benefit of those joining us from France, (foreign language).
I would now like to hand you over to James McCarthy. Good afternoon.
James Martin McCarthy - Novacyt S.A. - CFO, Acting CEO, Company Secretary & Director
Thank you, [Alexandre]. Good afternoon, everybody. Welcome to the Novacyt half year results. I should just start by showing the disclaimer. And I'll just take that as read by everybody before we proceed.
Okay. So my name is James McCarthy. I'm the acting CEO of Novacyt since November last year, and prior to that, I've been almost 2 years as the CEO of the group. Delighted to be joined by Steve Gibson, who is the Finance Director; and Lyn Rees, who recently joined us from the Yourgene's acquisition. So perhaps if I ask those 2 gentlemen to introduce themselves before we proceed?
Steve Gibson - Novacyt S.A. - Group
Half Year 2023 Novacyt SA Investor webinar Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers